Skip to main
BLLN

Billiontoone Inc (BLLN) Stock Forecast & Price Target

Billiontoone Inc (BLLN) Analyst Ratings

Based on 7 analyst ratings
Buy
Strong Buy 43%
Buy 29%
Hold 29%
Sell 0%
Strong Sell 0%

Bulls say

BillionToOne is a leading molecular diagnostics company with a strong portfolio of ultrasensitive tests and a unique molecular counting platform. With increasing demand and expansion into new markets, the company is expected to see continued growth in revenue and profitability. While facing competition and reimbursement challenges, BillionToOne has a solid position in the market and potential for future launches and expansions.

Bears say

BillionToOne is dependent on partnerships for their success in the prenatal market, and their recent announcement of a new product, Unity Confirm, may not be enough to differentiate them in the highly competitive market. Additionally, the company's reliance on senior leadership could pose a risk, and their pipeline and product timing may not meet expected timelines. With competition in the molecular diagnostics market increasing, BillionToOne may struggle to maintain market share and expand into new markets.

Billiontoone Inc (BLLN) has been analyzed by 7 analysts, with a consensus rating of Buy. 43% of analysts recommend a Strong Buy, 29% recommend Buy, 29% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Billiontoone Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Billiontoone Inc (BLLN) Forecast

Analysts have given Billiontoone Inc (BLLN) a Buy based on their latest research and market trends.

According to 7 analysts, Billiontoone Inc (BLLN) has a Buy consensus rating as of May 19, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $125.29, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $125.29, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Billiontoone Inc (BLLN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.